References
- Akin S, Soliman O, de By T, Muslem R, Tijssen JGP, Schoenrath F, Meyns B, Gummert JF, Mohacsi P, Caliskan K, et al. Causes and predictors of early mortality in patients treated with left ventricular assist device implantation in the European Registry of Mechanical Circulatory Support (EUROMACS). Intensive Care Med 2020;46(7):1349–1360[ Epub 2020/02/06]. doi:https://doi.org/10.1007/s00134-020-05939-1.
- Gosev I, Kiernan MS, Eckman P, Soleimani B, Kilic A, Uriel N, Rich JD, Katz JN, Cowger J, Lima B, et al. Long-term survival in patients receiving a continuous-flow left ventricular assist device. Ann Thorac Surg 2018;105(3):696–701[ Epub 2017/12/05]. doi:https://doi.org/10.1016/j.athoracsur.2017.08.057.
- Schmitto JD, Pya Y, Zimpfer D, Krabatsch T, Garbade J, Rao V, Morshuis M, Beyersdorf F, Marasco S, Sood P, et al. Long-term evaluation of a fully magnetically levitated circulatory support device for advanced heart failure-two-year results from the HeartMate 3 CE Mark Study. Eur J Heart Fail 2019;21(1):90–97. doi:https://doi.org/10.1002/ejhf.1284.
- Magunia H, Schibilsky D, Hilberath JN, Schlensak C, Rosenberger P, Nowak-Machen M. Echocardiographic features of the fully magnetically levitated LVAD. JACC: Cardiovascular Imaging 2017;10(7):819–822. [ Epub 2016/08/29]. doi:https://doi.org/10.1016/j.jcmg.2016.04.005.
- Kirklin JK, Pagani FD, Kormos RL, Stevenson LW, Blume ED, Myers SL, Miller MA, Baldwin JT, Young JB, Naftel DC. Eighth annual INTERMACS report: special focus on framing the impact of adverse events. J Heart Lung Transplant 2017;36(10):1080–1086. [ Epub 2017/09/26]. doi:https://doi.org/10.1016/j.healun.2017.07.005.
- Consolo F, Sferrazza G, Motolone G, Contri R, Valerio L, Lembo R, Pozzi L, Della Valle P, De Bonis M, Zangrillo A, et al. Platelet activation is a preoperative risk factor for the development of thromboembolic complications in patients with continuous-flow left ventricular assist device. Eur J Heart Fail 2018;20(4):792–800. doi:https://doi.org/10.1002/ejhf.1113.
- Rondina MT, Weyrich AS, Zimmerman GA. Platelets as cellular effectors of inflammation in vascular diseases. Circ Res 2013;112(11):1506–1519. [ Epub 2013/05/25]. doi:https://doi.org/10.1161/CIRCRESAHA.113.300512.
- Granja TF, Köhler D, Schad J, de Oliveira Franz CB, Konrad F, Hoch-Gutbrod M, Streißenberger A, Rosenberger P, Straub A. Adenosine receptor adora2b plays a mechanistic role in the protective effect of the volatile anesthetic sevoflurane during liver ischemia/reperfusion. Anesthesiology 2016;125(3):547–560. doi:https://doi.org/10.1097/ALN.0000000000001234.
- Köhler D, Straub A, Weissmuller T, Faigle M, Bender S, Lehmann R, Wendel H-P, Kurz J, Walter U, Zacharowski K, et al. Phosphorylation of vasodilator-stimulated phosphoprotein prevents platelet-neutrophil complex formation and dampens myocardial ischemia-reperfusion injury. Circulation 2011;123(22):2579–2590[ Epub 2011/05/25]. doi:https://doi.org/10.1161/CIRCULATIONAHA.110.014555.
- Köhler D, Birk P, Konig K, Straub A, Eldh T, Morote-Garcia JC, Rosenberger P, Eltzschig HK. Phosphorylation of Vasodilator-Stimulated Phosphoprotein (VASP) dampens hepatic ischemia-reperfusion injury. PLoS One 2011;6(12):e29494. [ Epub 2012/01/05]. doi:https://doi.org/10.1371/journal.pone.0029494.
- Granja T, Schad J, Schüssel P, Fischer C, Häberle H, Rosenberger P, Straub A. Using six-colour flow cytometry to analyse the activation and interaction of platelets and leukocytes – a new assay suitable for bench and bedside conditions. Thromb Res 2015;136(4):786–796. doi:https://doi.org/10.1016/j.thromres.2015.07.009.
- Granja T, Körner A, Glück C, Hohmann JD, Wang X, Köhler D, Streissenberger A, Nandurkar HH, Mirakaj V, Rosenberger P, et al. Targeting CD39 toward activated platelets reduces systemic inflammation and improves survival in sepsis: a preclinical pilot study. Crit Care Med 2019;47(5):e420–e427. doi:https://doi.org/10.1097/CCM.0000000000003682.
- FlowJo. Becton, Dickinson and Company; 2020. [cited 2020 Nov 21]. Available from: https://docs.flowjo.com/flowjo/workspaces-and-samples/ws-statistics/ws-statdefinitions/
- Tangri S, Vall H, Kaplan D, Hoffman B, Purvis N, Porwit A, Hunsberger B, Shankey TV, Group IIW. Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS - part III - analytical issues. Cytometry B Clin Cytom 2013;84(5):291–308. [ Epub 2013/09/12]. doi:https://doi.org/10.1002/cyto.b.21106.
- Noguchi K, Gel YR, Brunner E, Konietschke F. nparLD: an R software package for the nonparametric analysis of longitudinal data in factorial experiments. J Stat Softw 2012;50(12):1–23. doi:https://doi.org/10.18637/jss.v050.i12.
- Gardiner EE, Andrews RK. Platelet receptor expression and shedding: glycoprotein Ib-IX-V and glycoprotein VI. Transfus Med Rev 2014;28(2):56–60. doi:https://doi.org/10.1016/j.tmrv.2014.03.001.
- Polasek J. Procoagulant potential of platelet α granules. Platelets 2004;15(7):403–407. doi:https://doi.org/10.1080/09537100410001721315.
- Gurney D, Lip GY, Blann AD. A reliable plasma marker of platelet activation: does it exist? Am J Hematol 2002;70(2):139–144. doi:https://doi.org/10.1002/ajh.10097.
- Jackson SP. The growing complexity of platelet aggregation. Blood 2007;109(12):5087–5095. doi:https://doi.org/10.1182/blood-2006-12-027698.
- Schmid E, Krajewski S, Bachmann D, Kurz J, Wendel HP, Rosenberger P, Balkau B, Peter K, Unertl K, Straub A. The volatile anesthetic sevoflurane inhibits activation of neutrophil granulocytes during simulated extracorporeal circulation. Int Immunopharmacol 2012;14(2):202–208. [ Epub 2012/07/25]. doi:https://doi.org/10.1016/j.intimp.2012.07.009.
- Weerasinghe A, Taylor KM. The platelet in cardiopulmonary bypass. Ann Thorac Surg 1998;66(6):2145–2152. doi:https://doi.org/10.1016/S0003-4975(98)00749-8.
- Krajewski S, Kurz J, Neumann B, Greiner TO, Stolz A, Balkau B, Peter K, Unertl K, Wendel HP, Straub A. Short-acting P2Y12 blockade to reduce platelet dysfunction and coagulopathy during experimental extracorporeal circulation and hypothermia. Br J Anaesth 2012;108(6):912–921. [ Epub 2012/ 03/01]. doi:https://doi.org/10.1093/bja/aer518.
- Muslem R, Caliskan K, Leebeek FWG. Acquired coagulopathy in patients with left ventricular assist devices. J Thromb Haemost 2018;16(3):429–440. doi:https://doi.org/10.1111/jth.13933.
- Mondal NK, Chen Z, Trivedi JR, Sorensen EN, Pham SM, Slaughter MS, Griffith BP, Wu ZJ. Association of oxidative stress and platelet receptor glycoprotein GPIbα and GPVI shedding during nonsurgical bleeding in heart failure patients with continuous-flow left ventricular assist device support. Asaio J 2018;64(4):462–471. doi:https://doi.org/10.1097/MAT.0000000000000680.
- Lukito P, Wong A, Jing J, Arthur JF, Marasco SF, Murphy DA, Bergin PJ, Shaw JA, Collecutt M, Andrews RK, et al. Mechanical circulatory support is associated with loss of platelet receptors glycoprotein Ibα and glycoprotein VI. J Thromb Haemost 2016;14(11):2253–2260. doi:https://doi.org/10.1111/jth.13497.
- Granja T, Hohenstein K, Schussel P, Fischer C, Prufer T, Schibilsky D, Wendel HP, Jaschonek K, Serna-Higuita L, Schlensak C, et al. Multi-modal characterization of the coagulopathy associated with extracorporeal membrane oxygenation. Crit Care Med 2020;48(5):e400–e408[ Epub 2020/03/03]. doi:https://doi.org/10.1097/CCM.0000000000004286.
- Kondo C, Tanaka K, Takagi K, Shimono T, Shinpo H, Yada I, Yuasa H, Kusagawa M, Akamatsu N, Tanoue K. Platelet dysfunction during cardiopulmonary bypass surgery. With special reference to platelet membrane glycoproteins. Asaio J 1993;39:M550–553. [ Epub 1993/07/01].
- Taylor MA. Release of beta-thromboglobulin during the preparation, in vitro storage and cryopreservation of platelet concentrates. J Clin Pathol 1983;36(7):811–815. doi:https://doi.org/10.1136/jcp.36.7.811.
- Boehlen F, Clemetson KJ. Platelet chemokines and their receptors: what is their relevance to platelet storage and transfusion practice? Transfus Med 2001;11(6):403–417. doi:https://doi.org/10.1046/j.1365-3148.2001.00340.x.
- Xu Y, Nakane N, Maurer-Spurej E. Novel test for microparticles in platelet-rich plasma and platelet concentrates using dynamic light scattering. Transfusion 2011;51(2):363–370. doi:https://doi.org/10.1111/j.1537-2995.2010.02819.x.
- Bronicki RA, Hall HM. Cardiopulmonary bypass-induced inflammatory response. Pediatr Crit Care Med 2016;17:S272–278. doi:https://doi.org/10.1097/PCC.0000000000000759.
- Schibilsky D, Lenglinger M, Avci-Adali M, Haller C, Walker T, Wendel HP, Schlensak C. Hemocompatibility of axial versus centrifugal pump technology in mechanical circulatory support devices. Artif Organs 2015;39:723–728.
- John R, Kamdar F, Liao K, Colvin–Adams M, Miller L, Joyce L, Boyle A. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device. J Thorac Cardiovasc Surg 2008;136(5):1318–1323. [ Epub 2008/11/26]. doi:https://doi.org/10.1016/j.jtcvs.2007.12.077.
- Pinney SP, Anyanwu AC, Lala A, Teuteberg JJ, Uriel N, Mehra MR. Left ventricular assist devices for lifelong support. J Am Coll Cardiol 2017;69(23):2845–2861. [ Epub 2017/06/10]. doi:https://doi.org/10.1016/j.jacc.2017.04.031.
- Yost G, Joseph CR, Royston T, Tatooles A, Bhat G. Heat generation in axial and centrifugal flow left ventricular assist devices. Asaio J 2016;62(6):684–689. doi:https://doi.org/10.1097/MAT.0000000000000438.
- Schmitto JD, Hanke JS, Rojas SV, Avsar M, Haverich A. First implantation in man of a new magnetically levitated left ventricular assist device (HeartMate III). J Heart Lung Transplant 2015;34(6):858–860. doi:https://doi.org/10.1016/j.healun.2015.03.001.
- Gurbel PA, Tantry US. Antiplatelet and anticoagulant agents in heart failure: current status and future perspectives. JACC Heart Fail 2014;2(1):1–14. [ Epub 2014/03/14]. doi:https://doi.org/10.1016/j.jchf.2013.07.007.
- Grote Beverborg N, van Veldhuisen DJ, van der Meer P. Anemia in heart failure: still relevant? JACC Heart Fail 2018;6(3):201–208. [ Epub 2017/11/13]. doi:https://doi.org/10.1016/j.jchf.2017.08.023.
- Silvain J, Pena A, Cayla G, Brieger D, Bellemain-Appaix A, Chastre T, Vignalou J-B, Beygui F, Barthelemy O, Collet J-P, et al. Impact of red blood cell transfusion on platelet activation and aggregation in healthy volunteers: results of the TRANSFUSION study. Eur Heart J 2010;31(22):2816–2821[ Epub 2010/07/02]. doi:https://doi.org/10.1093/eurheartj/ehq209.
- van Hezel ME, van Manen L, Boshuizen M, Straat M, De Cuyper IM, Beuger B, Nieuwland R, Tanck MWT, de Korte D, Zwaginga JJ, et al. The effect of red blood cell transfusion on platelet function in critically ill patients. Thromb Res 2019;184:115–121. [ Epub 2019/11/16]. doi:https://doi.org/10.1016/j.thromres.2019.10.028.
- Garraud O, Tariket S, Sut C, Haddad A, Aloui C, Chakroun T, Laradi S, Cognasse F. Transfusion as an inflammation hit: knowns and unknowns. Front Immunol 2016;7:534. [ Epub 2016/12/15]. doi:https://doi.org/10.3389/fimmu.2016.00534.
- Montague SJ, Lim YJ, Lee WM, Gardiner EE. Imaging platelet processes and function-current and emerging approaches for imaging in vitro and in vivo. Front Immunol 2020;11:78. [ Epub 2020/02/23]. doi:https://doi.org/10.3389/fimmu.2020.00078.